Literature DB >> 9094971

Increased expression of telomerase RNA component is associated with increased cell proliferation in human astrocytomas.

P Sallinen1, H Miettinen, S L Sallinen, H Haapasalo, H Helin, J Kononen.   

Abstract

Deregulation of telomerase, a ribonucleoprotein polymerase that compensates progressive loss of telomeric (TTAGGG)n repeats during DNA replication, has been suggested to facilitate tumorigenesis and cellular immortality by providing unlimited proliferation capacity for cancer cells. We investigated the relationship between tumor proliferation activity and in situ expression of the telomerase RNA component in 46 human grade I to IV astrocytomas. Heterogeneously distributed telomerase RNA expression was detected from all of the tumor samples as well as from normal human brain tissue. However, expression of telomerase RNA was significantly increased in highly malignant tumors (P = 0.024) and in tumors that showed increased proliferation activity determined by MIB-1 immunohistochemistry (P = 0.014). Interestingly, increased telomerase RNA levels were observed in a subgroup of grade II astrocytomas that showed significant increase in proliferation activity (P = 0.047), indicating that the telomerase RNA component is up-regulated already in early states of astrocytoma malignancy. Telomeric repeats amplification assays revealed telomerase activity in 4 of 6 glioblastomas and in 1 rapidly proliferating grade II astrocytoma. These results suggest that increased tumor proliferation activity triggers telomerase activation via mechanisms that involve increased production of the telomerase RNA component.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094971      PMCID: PMC1858183     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  14 in total

1.  Telomere positional effects and the regulation of cellular senescence.

Authors:  W E Wright; J W Shay
Journal:  Trends Genet       Date:  1992-06       Impact factor: 11.639

2.  Telomere end-replication problem and cell aging.

Authors:  M Z Levy; R C Allsopp; A B Futcher; C W Greider; C B Harley
Journal:  J Mol Biol       Date:  1992-06-20       Impact factor: 5.469

Review 3.  Telomere loss: mitotic clock or genetic time bomb?

Authors:  C B Harley
Journal:  Mutat Res       Date:  1991 Mar-Nov       Impact factor: 2.433

Review 4.  Structure and function of telomeres.

Authors:  E H Blackburn
Journal:  Nature       Date:  1991-04-18       Impact factor: 49.962

5.  Runaway telomere elongation caused by telomerase RNA gene mutations.

Authors:  M J McEachern; E H Blackburn
Journal:  Nature       Date:  1995-08-03       Impact factor: 49.962

6.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

7.  Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.

Authors:  G Cattoretti; M H Becker; G Key; M Duchrow; C Schlüter; J Galle; J Gerdes
Journal:  J Pathol       Date:  1992-12       Impact factor: 7.996

8.  Specific association of human telomerase activity with immortal cells and cancer.

Authors:  N W Kim; M A Piatyszek; K R Prowse; C B Harley; M D West; P L Ho; G M Coviello; W E Wright; S L Weinrich; J W Shay
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

9.  Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis.

Authors:  M A Blasco; M Rizen; C W Greider; D Hanahan
Journal:  Nat Genet       Date:  1996-02       Impact factor: 38.330

10.  Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples.

Authors:  P K Sallinen; H K Haapasalo; T Visakorpi; P T Helén; I S Rantala; J J Isola; H J Helin
Journal:  J Pathol       Date:  1994-12       Impact factor: 7.996

View more
  10 in total

1.  Establishment of novel human esophageal cancer cell line in relation to telomere dynamics and telomerase activity.

Authors:  Y Kiyozuka; A Asai; D Yamamoto; H Senzaki; S Yoshioka; H Takahashi; K Hioki; A Tsubura
Journal:  Dig Dis Sci       Date:  2000-05       Impact factor: 3.199

2.  Telomerase expression in uveal melanoma.

Authors:  B Heine; S E Coupland; S Kneiff; G Demel; N Bornfeld; M Hummel; H Stein
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

3.  Telomerase activity in gestational trophoblastic disease.

Authors:  A N Cheung; D K Zhang; Y Liu; H Y Ngan; D H Shen; S W Tsao
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

4.  Telomerase activity and expression of telomerase RNA component and telomerase catalytic subunit gene in cervical cancer.

Authors:  K Nakano; E Watney; J K McDougall
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

5.  Prognostic value of proliferation index and expression of the RNA component of human telomerase (hTR) in papillary meningiomas.

Authors:  E J Rushing; S M Colvin; A Gazdar; N Miura; C L White; C Coimbra; D K Burns
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

6.  Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.

Authors:  B K Kleinschmidt-DeMasters; T L Hashizumi; C I Sze; K O Lillehei; A L Shroyer; K R Shroyer
Journal:  J Clin Pathol       Date:  1998-04       Impact factor: 3.411

7.  Telomerase activity in human brain tumors: astrocytoma and meningioma.

Authors:  Majid Kheirollahi; Masoud Mehrazin; Naser Kamalian; Javad Mohammadi-asl; Parvin Mehdipour
Journal:  Cell Mol Neurobiol       Date:  2013-03-20       Impact factor: 5.046

8.  Telomerase activity in plasma cell dyscrasias.

Authors:  D Xu; C Zheng; S Bergenbrant; G Holm; M Björkholm; Q Yi; A Gruber
Journal:  Br J Cancer       Date:  2001-03-02       Impact factor: 7.640

Review 9.  Telomere and Telomerase Therapeutics in Cancer.

Authors:  Yucheng Xu; Amir Goldkorn
Journal:  Genes (Basel)       Date:  2016-05-26       Impact factor: 4.096

10.  In situ mRNA hybridization technique for analysis of human telomerase RNA in gastric precancerous and cancerous lesions.

Authors:  T Hiyama; H Yokozaki; Y Kitadai; E Tahara; H Tahara; T Ide; K Haruma; W Yasui; G Kajiyama; E Tahara
Journal:  Jpn J Cancer Res       Date:  1998-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.